RBMY2XP

Across TCGA pan-cancer cohorts, RBMY2XP RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RBMY2XP data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RBMY2XP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RBMY2XP expression acts as an unfavorable survival marker.

KIRC are the cancer types where RBMY2XP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.138	0.655	.021	36	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

RBMY2XP–KIRC (OS)

Open the KIRC breakdown →